Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
NPC Blog
NPC Blog
2010 Archives
2009 Archives
2008 Archives
2007 Archives
2006 Archives
Search Archives
Archives
  • December 2012 (3)
  • November 2012 (1)
  • October 2012 (1)
  • May 2012 (1)
  • December 2011 (1)
  • November 2011 (3)
  • October 2011 (4)
  • September 2011 (4)
  • August 2011 (6)
  • July 2011 (13)
  • June 2011 (8)
  • May 2011 (10)
  • April 2011 (14)
  • March 2011 (6)
  • February 2011 (2)
  • February 2010 (4)
  • January 2010 (1)
  • December 2009 (1)
  • November 2009 (1)
  • October 2009 (1)
  • September 2009 (2)
  • July 2009 (1)
  • April 2009 (1)
  • March 2009 (1)
  • February 2009 (1)
  • December 2008 (1)
  • October 2008 (1)
  • September 2008 (1)
  • August 2008 (2)
  • July 2008 (2)
  • June 2008 (4)
  • May 2008 (1)
  • April 2008 (1)
  • March 2008 (4)
  • February 2008 (1)
  • April 2007 (1)
  • December 2006 (1)
  • October 2006 (1)
  • September 2006 (1)
  • July 2006 (2)
  • June 2006 (3)
  •  

    Subscribe in a reader

    E-Alerts
    Signup to receive news and announcements from Nutra Pharma:
    First Name:
    Last Name:
    Email:
     
    Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

    NPC Blog

    Archive for June, 2008

    Nontuberculous Mycobacteria, also known as atypical mycobacteria and mycobacteria other than tuberculosis (MOTT), is bacteria that most of us have never head of, yet it’s one of the primary causes of respiratory diseases in humans and a leading cause of death in HIV patients. Additionally, many believe that one type of NTM, paratuberculosis, which can [...]

    Read Full Post »

     

    Often times, when I tell people that I work for a biotech company developing a treatment for Multiple Sclerosis (MS) using cobra venom, I receive the strangest feedback. I agree that at first-glance cobras may seem an unlikely source for treating anything, but when one digs deeper, it become apparent that snakes may hold the [...]

    Read Full Post »

     

    Navigating the FDA Approval Process

    Posted on Jun 12th, 2008

    Navigating through the FDA approval process can be an expensive, complicated, and time-consuming endeavor for any pharmaceutical company. Traditionally, this process is divided into four phases, but can also include an additional phase (Phase IV or Post Marketing Surveillance Trial) after the drug is approved. As we complete our Phase IIb/IIIa trial for the treatment [...]

    Read Full Post »

     

    As we continue to celebrate our recent acquisition of ReceptoPharm, I would like to take a moment and welcome Dr. Paul Reid and Mr. Harold Rumph to the Nutra Pharma Board of Directors. For the past several years, I have had the pleasure of working closely with both Dr. Reid and Mr. Rumph at ReceptoPharm. [...]

    Read Full Post »

     

     
    Quick Nav
    Nyloxin // Chronic Pain Relief
    Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
     

     

     
    Recent News
     
    March 14, 2017
    Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com


    February 22, 2017
    Global Small Caps Initiates Coverage on Nutra Pharma


    February 15, 2017
    Nutra Pharma and Nyloxin Featured on NBC News-Miami


     
     
     
    Announcements
    Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
     
     
    Facebook   Twitter
     
    NPC
    Privacy Policy Code of Ethics